Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (636)
  2. Journal Article (509)
  3. Review (142)
  4. Editorial (64)
  5. Research Letter (50)
  6. Correspondence (15)
  7. Guidelines (6)
  8. Book Section (3)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (1165)
  2. Graduate Medical Education (1122)
  3. GME, Medicine (1098)
  4. Hematologic Malignancies, Division of (752)
  5. Weinberg Fellows (660)
  6. Solid Tumor Oncology Division (617)

More Groups

People
  1. Jan Bewersdorf (102)
  2. Maria Palomba (94)
  3. Zachary Epstein-Peterson (94)
  4. Gunjan Shah (93)
  5. Gilles Salles (89)
  6. Michael Scordo (87)

More People

Years
  1. 2025 (165)
  2. 2024 (357)
  3. 2023 (296)
  4. 2022 (222)
  5. 2021 (159)
  6. 2020 (114)

More Years

Publications
  1. Blood (288)
  2. Journal of Clinical Oncology (219)
  3. Clinical Cancer Research (38)
  4. Annals of Oncology (35)
  5. Cancer Research (35)
  6. Journal of Thoracic Oncology (31)

More Publications

Publishers
  1. American Society of Hematology (323)
  2. American Society of Clinical Oncology (251)
  3. Elsevier Inc. (143)
  4. Nature Publishing Group (107)
  5. American Association for Cancer Research (104)
  6. Oxford University Press (61)

More Publishers

Results (1429)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pericytes are protective in experimental pneumococcal meningitis through regulating leukocyte infiltration and blood–brain barrier function
    Journal Article

    Teske, N. C.; Dyckhoff-Shen, S.; Beckenbauer, P.; Bewersdorf, J. P.; Engelen-Lee, J. Y.; Hammerschmidt, S.; Kälin, R. E.; Pfister, H. W.; Brouwer, M. C.; Klein, M.; more...
    Journal of Neuroinflammation (2023)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Facts and hopes in colorectal cancer immunotherapy
    Review

    Foote, M. B.; Argilés, G.; Rousseau, B.; Segal, N. H.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • The ratio of key metabolic transcripts is a predictive biomarker of breast cancer metastasis to the lung
    Journal Article

    Mathur, D.; Liao, C.; Lin, W.; La Ferlita, A.; Alaimo, S.; Taylor, S.; Zhong, Y.; Iacobuzio-Donahue, C.; Ferro, A.; Xavier, J. B.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers
    Journal Article

    Jiagge, E.; Jin, D. X.; Newberg, J. Y.; Perea-Chamblee, T.; Pekala, K. R.; Fong, C.; Waters, M.; Ma, D.; Dei-Adomakoh, Y.; Erb, G.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • An embarrassment of riches: Three FDA-approved bispecific antibodies for relapsed refractory multiple myeloma
    Review

    Firestone, R.; Lesokhin, A. M.; Usmani, S. Z.
    Blood Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Allogeneic CAR T cells with regulated NEF expression display immune evasion and optimized signaling
    Meeting Abstract

    Perica, K.; Mansilla-Soto, J.; Kotchetkov, I.; Sadelain, M.
    Molecular Therapy (2023)

    Fulltext@MSK | Save
  • Institutional experience of routine genomic profiling of cell-free DNA from cerebrospinal fluid across a wide range of malignancies
    Meeting Abstract

    Hickman, R.; Miller, A.; Jee, J.; Liu, S.; Pentsova, E.; Holle, B.; Ross, D.; Nandakumar, S.; Vanderbilt, C.; Rana, S.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • SVR (spleen volume reduction) predicts OS (overall survival) in MF (myelofibrosis) patients on PAC (pacritinib) but not BAT (best available therapy): PERSIST-2 landmark OS analysis
    Meeting Abstract

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save